Our esteemed speakers
Richard J. Gralla, MD FACP
Director of Oncology Research, Albert Einstein College of Medicine, Jacobi Medical Center, and Professor of Medicine, in New York.
Author or co-author of over 250 scientific articles and book chapters. Board member of the Multinational Association of Supportive Care in Cancer and of the oncology section of the International Society for Chemotherapy. Holds memberships in the American Society of Clinical Oncology, the American Association for Cancer Research, the International Association for the Study of Lung Cancer, and the Oncology Nursing Society. Past-President of the Multinational Association of Supportive Care in Cancer and Past-President of the New York Lung Cancer Alliance.
Jeffrey Crawford, MD
George Barth Geller Professor for Research in Cancer, Duke University Medical Center
Co-Director of the Solid Tumor Therapeutics Program, Duke Cancer Institute (DCI), Durham, North Carolina
Principal Investigator for the National Clinical Trials Network Lead Academic Site Grant at Duke. Member of the executive committee for the Alliance and Chair of NCCN Myeloid Growth Factors Panel.
Athina Vadalouca MD PhD
Associate Professor of Anaesthesia, Pain Relief & Palliative Care, University of Athens ,GREECE; Fellow of Interventional Pain Practice of WIP(FIPP); President of the Hellenic Society of Pain Therapy and Palliative Care; Visiting Prof. of the University of L’Aquila,Italy; Visiting Prof.of the University of Istanbul,Turkey
Matti S. Aapro MD PhD
Clinique de Genolier
Dean of the Multidisciplinary Oncology Institute, Genolier, Switzerland.
He serves the International Society for Geriatric Oncology (SIOG) as Executive Board Member.
He was member of the Board of the European Organization for Research and Treatment of
Cancer (EORTC). He is past-President of the Multinational Association for Supportive Care in
Cancer (MASCC), and is now on its Board of Directors for 2012-2014.
Fausto Roila MD PhD
Director of Medical Oncology, Santa Maria Hospital, Terni, Italy
Member of the Board of the Multinational Association of Supportive Care in Cancer (MASCC)
Member of the Consultant Committee for the Oncological Drugs of the Italian Agency of the Drugs (A.I.F.A.), of the Ethical Committee of Aziende Sanitarie of Umbria and of the Committee of Hospital Therapeutic Formulary of Umbria Region.
Alberto Fusi MD PhD
Charité – Comprehensive Cancer Centre – Berlin, Lead of the Melanoma Clinical Trials Unit
The Christie Hospital NHS Foundation Trust – Manchester, Medical Oncologist working within the Melanoma and Lung Cancer Team
Charitè – Campus Benjamin Franklin – Berlin, Hematology and Oncology Department, Postdoctoral fellow involved in translational research studies and coordination of a side study of the EORTC 18991 trial. Medical oncologist, Lab Team leader for the evaluation and characterization of circulating tumour cells in patients with solid tumours.
Carla Ida Ripamonti MD
Carla Ida Ripamonti, M.D. specialized in medical oncology and clinical pharmacology , Head of Supportive Care in Cancer Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy, Lifetime Board Advisers of IAHPC; ESMO Faculty Member Educational Committee Supportive and Palliative Care; Member of Directors of the ESMO Palliative Care Working Group (PCWG), Member of Directors of the MASCC, Vice Director of Italian Network of Supportive Care in Cancer (NICSO)
Jørn Herrstedt MD DMSc
Chief Consultant and Professor in Clinical Oncology, Section of Gynaecologic Oncology, Department of Oncology, Odense University Hospital, Denmark and the University of Southern Denmark. Head of Research and of the Elite Research Centre, Academy of Geriatric Cancer Research (AgeCare).
Emeritus Professor Sam H Ahmedzai
Emeritus Professor at the Medical School at University of Sheffield, with 30 years’ experience of being consultant physician in palliative medicine. Sam chaired the 2015 UK NICE guideline for care of the dying adult (NG31) and he is clinical advisor to the new NICE guideline committee on service delivery in the last year of life. He is clinical lead for the Royal College of Physicians of London’s national audit of end of life care, published in March 2016. He is NIHR national specialty lead for cancer research outside the acute hospital and chairs the NCRI’s Clinical Studies Group on Supportive and Palliative Care. Sam is editor in chief of ‘Current Opinion in Supportive and Palliative Care’ and of the Oxford Textbook series on ‘Supportive Care’.
Federico Bozzetti, MD
Private oncologic surgeon and war surgeon in Cambodia and Africa through EMERGENCY, an Italian NGO. Former Head of Dept Surgery, Hospital of Prato. Former Clinical and Scientific Co-ordinator of the Department of Oncology at the Centro Regionale di Oncologia Basilicata (CROB) in Rionero in Vulture (PZ). Member of numerous professional and scientific societies, as well as editorial boards. Areas of scientific interest: Treatment of tumours of the gastrointestinal tract, Surgical treatment and loco-regional therapy in the primitive and secondary tumours of the liver, Surgical asepsis, Artificial Nutrition (TPN / EN), Orthotopic liver transplantation (performed several experimental liver transplantation on pigs), Cancer Wasting.
Marcin Janecki, MD
Dr Marcin Janecki has been working in Department of Palliative Care and Palliative Medicine Chair of Nursery Faculty of Health Sciences Medical University of Silesia in Katowice since 2001- initially as an Assisstant, and since 2009 as a Head of Department. Since 1998 he has been working in several home and stationary palliative care units, currently in Gliwice Hospice. Additionally, since 2006, he has been working in Out-Patient Pain Clinic of University Teaching Hospital in Katowice.
Dr Janecki is a Board Member of Polish Association for Palliative Medicine and member of European Association for Palliative Care (EAPC), Polish Association for the Study of Pain, International Association for the Study of Pain (IASP).
Clare Donellan, BSc, MBBS, MD, FRCP
Clare Donnellan is a consultant gastroenterologist working in Leeds, one of the largest teaching hospitals in the UK. She has a special interest in nutrition, running a large service of approximately 140 patients receiving home parenteral nutrition. She also looks after patients with acute cancer therapy-related diarrhoea (often due to immunotherapy) and in particular those patients with late cancer gastrointestinal effects, some of whom end up on home parenteral nutrition.
Hartmut Link, MD, Professor
Past Head, Department Internal Medicine, Hematology, Oncology; Kaiserslautern, Germany,
Academic Medical Center of the Universities of Mainz and of Mannheim-Heidelberg
Dr. med., Professor of Medicine, external faculty at University Medical Center Hannover, Germany
He has authored numerous publications in peer reviewed journals, textbooks on leukaemia, solid tumours, supportive care, infectious diseases, and serves as reviewer for several international journals. He is member of many
international and national scientific and professional societies, and working on evidence based guidelines in solid tumours, supportive care, hematopoietic growth factors and infections.
Sandro Barni, MD, Professor
Director of Division of Medical Oncology – Azienda Ospedaliera Treviglio-Caravaggio, member of Regional Oncological Department of Bergamo, member of Ethic Committee of Provincia di Bergamo, former Professor of Medical Oncology at the University of Pavia.
Member of many professional societies, among them National Board of CIPOMO (Collegio Italiano Primari Oncologi Medici Ospedalieri), Italian Society of Osteo-oncology, Management Committee of ITMO, Vice president of Italian Association of Cardio-oncology.
Numerous editorial works and publications (over 600 papers).
Ms Snezana Bosnjak, MD, PhD, Research Professor, Clinical Pharmacologist
Research Professor Snežana Bošnjak, MD, PhD, is a Clinical Pharmacologist in the Supportive Oncology Service at the Institute for Oncology and Radiology of Serbia in Belgrade, Serbia, where she specializes in the pharmacotherapy of symptoms of malignant disease and toxicities induced by anticancer treatment. Dr Bošnjak has long been actively involved in supportive & palliative care education and research, in efforts to improve the availability of essential medications, and in efforts to improve national policy regarding supportive and palliative care. She has been instrumental in introducing the philosophy of supportive oncology in Serbia.
Jovanović M. Dragana, MD, Phd, Professor
Head of the Paliative medicine department at the Medical Faculty, Belgrade University. Works at the Pulmology Clinic at Serbian Clinical Center, Belgrade, since 1979. Author/co-author of more than 320 scientific papers, and more than 40 book chapters in various publications and textbooks. President of Serbian Respiratory Association, member of Serbian Medical Association, European Respiratory Society (ERS), CHEST ACCP, ESMO and IASLC. Member of ERS College of Experts and ERS Task Force Thoracic Oncology. Member of Royal Medical Board HRH Karadjordjević and several international expert boards.
Snežana Šušnjar, MD, PhD
Specialized in internal medicine and work at the Institute for Oncology and Radiology of Serbia, Department for Medical Oncology, Intensive Oncology Care and Supportive Oncology Unit. Member of the Board of Oncology Section of the Serbian Medical Association and Scientific Board of the Institute. Member of the Board of the Serbian Society for Medical Oncology and ESMO national representative since 2014.
